Based on recent data, Nektar Therapeutics (NKTR) shows an Average True Range (ATR) of 4.61 and an Enterprise Value of 463.63M. Its average trading volume over the past 3 months is 1.09M, indicating liquidity. These fundamental metrics provide insight into NKTR's underlying financial health and market activity.
| ATR | 4.61 |
| Enterprise Value | 463.63M |
| Avg Vol (3 Months) | 1.09M |
| Avg Vol (10 Days) | 1.1M |
Nektar Therapeutics (NKTR) technical indicators as of February 26, 2026: the SMA 20 is 27.51%, SMA 50 at 48.93%, and SMA 200 at 78.13%. The RSI 14 value is 71.09, suggesting its current momentum. These technical analysis signals help assess NKTR's price trends and potential future movements.
| SMA 20 | 27.51% |
| SMA 50 | 48.93% |
| SMA 200 | 78.13% |
| RSI 14 | 71.09 |
Nektar Therapeutics (NKTR) stock performance overview as of February 26, 2026: The 52-week high is $75.67 (currently -7% below), and the 52-week low is $0.432 (currently 16,189.35% above). Over the past year, NKTR's performance is 170.87%, compared to the S&P 500's 10.91% change.
| 52-Week High | 75.67 |
| 52-Week High Chg | -7.00% |
| 52-Week Low | 0.432 |
| 52-Week Low Chg | +16,189.35% |
| S&P 500 52-Week Chg | 10.91% |
According to market data, Nektar Therapeutics (NKTR) stock's recent performance metrics show that over the last month, NKTR is -20.25%, with a Year-to-Date (YTD) performance of -14.31%. Over the past year, the stock has seen a 170.87% change. These figures summarize NKTR's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 75.67 | 75.67 | 75.67 | 75.67 | 75.67 | 75.67 |
| Low | 68.2 | 33.4 | 33.4 | 26.45 | 0.432 | 33.4 |
| Performance | -6.55% | -20.25% | -37.29% | +46.15% | +170.87% | -14.31% |
According to current financial data, NKTR stock's P/E (TTM) ratio is -8.19, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for NKTR, including P/S (22.82), P/B (11.63), and P/FCF (-7.51), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | NKTR | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -8.19 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 22.82 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 11.63 | 115.64 | 9 | 5.26 |
| P/FCF (TTM) | -7.51 | -0.18 | -253.28 | 30.85 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep